Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Italian Journal of Neurological Sciences
|
April 1, 1995
Brain MRI and SPET in thrombotic thrombocytopenic purpura
L Fiorani, N Vianelli, L Gugliotta, et al.
American Journal of Hematology
|
August 1, 1993
Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa
C Finelli, L Gugliotta, B Gamberi, et al.
British Journal of Haematology
|
January 1, 1993
Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia
G Zauli, G Visani, L Catani, et al.
Annals of Hematology
|
May 16, 2015
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
N Polverelli, L Catani, N Vianelli, et al.
Haematologica
|
November 1, 1996
Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia
E Zuffa, N Vianelli, G Martinelli, et al.
Blood
|
February 1, 1994
Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia
N Vianelli, L Gugliotta, S Tura, et al.
American Journal of Hematology
|
July 1, 1996
Thrombotic thrombocytopenic purpura and relapses: why do case series differ? The Italian Cooperative Group for TTP
C Porta, R Centurioni, N Vianelli, et al.
Haematologica
|
January 1, 1992
Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP)
N Vianelli, L Gugliotta, L Gianni, et al.
Haematologica
|
October 30, 1998
Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura
N Vianelli, P L Tazzari, S Baravelli, et al.
Stem Cells (Dayton, Ohio)
|
July 21, 2001
Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines
L Catani, M Amabile, S Luatti, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Italian Journal of Neurological Sciences
|
April 1, 1995
Brain MRI and SPET in thrombotic thrombocytopenic purpura
L Fiorani, N Vianelli, L Gugliotta, et al.
American Journal of Hematology
|
August 1, 1993
Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa
C Finelli, L Gugliotta, B Gamberi, et al.
British Journal of Haematology
|
January 1, 1993
Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia
G Zauli, G Visani, L Catani, et al.
Annals of Hematology
|
May 16, 2015
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
N Polverelli, L Catani, N Vianelli, et al.
Haematologica
|
November 1, 1996
Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia
E Zuffa, N Vianelli, G Martinelli, et al.
Blood
|
February 1, 1994
Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia
N Vianelli, L Gugliotta, S Tura, et al.
American Journal of Hematology
|
July 1, 1996
Thrombotic thrombocytopenic purpura and relapses: why do case series differ? The Italian Cooperative Group for TTP
C Porta, R Centurioni, N Vianelli, et al.
Haematologica
|
January 1, 1992
Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP)
N Vianelli, L Gugliotta, L Gianni, et al.
Haematologica
|
October 30, 1998
Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura
N Vianelli, P L Tazzari, S Baravelli, et al.
Stem Cells (Dayton, Ohio)
|
July 21, 2001
Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines
L Catani, M Amabile, S Luatti, et al.
Page
of 7